BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1351798)

  • 1. The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy.
    Parera M; Rivera F; Egido J; Campos A
    Clin Immunol Immunopathol; 1992 May; 63(2):196-9. PubMed ID: 1351798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.
    Lai KN; Leung JC; Lai FM
    Clin Nephrol; 1988 Dec; 30(6):330-4. PubMed ID: 2977310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of interleukin-2 (IL-2) and expression of IL-2 receptor in patients with IgA nephropathy.
    Lee TW; Kim MJ
    Korean J Intern Med; 1992 Jan; 7(1):31-8. PubMed ID: 1477028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.
    Lai KN; Leung JC; Lai FM; Tam JS
    J Clin Immunol; 1989 Nov; 9(6):485-92. PubMed ID: 2630571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell alterations in immunoglobulin A nephropathy.
    Campos A; Rivera F; Egido J; Parera M
    Int J Clin Pharmacol Res; 1992; 12(4):191-5. PubMed ID: 1297642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of interleukin-2 and IL-2 receptor in primary IgA nephropathy.
    Schena FP; Mastrolitti G; Jirillo E; Munno I; Pellegrino N; Fracasso AR; Aventaggiato L
    Kidney Int; 1989 Mar; 35(3):875-9. PubMed ID: 2785227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
    Shahabuddin S
    J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
    Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
    Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
    Meier P; Dayer E; Ronco P; Blanc E
    Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
    Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
    Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
    Fagiolo E; Abenante L
    Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine production by peripheral blood mononuclear cells in IgA nephropathy.
    Lai KN; Leung JC; Li PK; Lui SF
    Clin Exp Immunol; 1991 Aug; 85(2):240-5. PubMed ID: 1907530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
    Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
    J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy.
    Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A
    Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
    Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
    Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-2 receptor in patients with glomerular diseases.
    Chen HS; Wu MS; Yen TS; Chen WY
    Postgrad Med J; 1995 Oct; 71(840):617-22. PubMed ID: 8545291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change.
    Hofmann B; Nishanian P; Fahey JL; Esmail I; Jackson AL; Detels R; Cumberland W
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):212-24. PubMed ID: 1680589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations of T lymphocyte subsets and IL-2, sIL-2R in patients with malignant ovarian tumor].
    Wang H; Peng Z; Zhang C
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):210-3. PubMed ID: 10683937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma.
    Yang J; Patil RV; Yu H; Gordon M; Wax MB
    Am J Ophthalmol; 2001 Apr; 131(4):421-6. PubMed ID: 11292402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo?
    Dummer R; Posseckert G; Nestle F; Witzgall R; Burger M; Becker JC; Schäfer E; Wiede J; Sebald W; Burg G
    J Invest Dermatol; 1992 Jan; 98(1):50-4. PubMed ID: 1728640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.